1. Home
  2. IDT vs VOR Comparison

IDT vs VOR Comparison

Compare IDT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

N/A

Current Price

$80.37

Market Cap

1.5B

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$18.08

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDT
VOR
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
IDT
VOR
Price
$80.37
$18.08
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $39.00
AVG Volume (30 Days)
207.5K
★ 1.1M
Earning Date
09-28-2026
11-12-2026
Dividend Yield
★ 0.35%
N/A
EPS Growth
★ 14.95
N/A
EPS
★ 3.46
N/A
Revenue
★ $1,231,495,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$28.98
★ N/A
Revenue Growth
★ 2.13
N/A
52 Week Low
$45.72
$6.50
52 Week High
$77.28
$39.49

Technical Indicators

Market Signals
Indicator
IDT
VOR
Relative Strength Index (RSI) 81.25 36.87
Support Level $47.72 $11.62
Resistance Level N/A $19.70
Average True Range (ATR) 2.60 1.23
MACD 1.11 -0.37
Stochastic Oscillator 96.21 23.02

Price Performance

Historical Comparison
IDT
VOR

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: